THYROID GLAND MEDULLARY CARCINOMA
Clinical trials for THYROID GLAND MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to shrink tough thyroid tumors before surgeons operate
Disease control OngoingThis study is testing whether a targeted pill called selpercatinib can shrink thyroid tumors before surgery. It is for people with advanced thyroid cancer that has a specific genetic change (RET alteration). The goal is to see if shrinking the tumor first makes surgery easier and…
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope pill tested for kids with tough cancers
Disease control OngoingThis study is testing whether a pill called cabozantinib can help control rare cancers that have come back or stopped responding to other treatments in children and young adults. It includes patients with sarcomas, Wilms tumor, and other rare tumors. The drug aims to slow or stop…
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New scan seeks hidden cancers
Diagnosis OngoingThis study is testing a new radioactive imaging agent to see if it can help find cancers that produce a specific protein called CEA. Twenty patients with various CEA-positive cancers will receive the agent and undergo PET scans to see if it highlights their tumors. The goal is to…
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC